InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,952.00
(
-0.19%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.83
(
0.34%
)
Bitcoin
57,528.32
(
-1.22%
)

Replies to post #204277 on Biotech Values

Replies to #204277 on Biotech Values

puravida

09/14/16 8:51 AM

#204278 RE: puravida #204277

Incredible premium for a company with only phase1 and phase 2 stage pipeline candidates.

DewDiligence

04/30/18 11:43 AM

#218770 RE: puravida #204277

AGN took a $535M (non-cash) charge in 1Q18 reflecting the worthlessness of the 2016 VTAE acquisition. The psoriasis program acquired from VTAE was recently canned due to toxicity.